Structural based investigation of novel pyrazole-thiazole Hybrids as dual CDK-1 and CDK-2 inhibitors for cancer chemotherapy

Post time 2022-3-11 09:35:47

journal：Molecular Simulation

Authors：Vincent A. Obakachi; Idowu Kehinde; Narva Deshwar Kushwaha; Olayinka I. Akinpelu; Babita Kushwaha; Srinivas Reddy Merugu; Francis Kayamba; Hezekiel M. Kumalo; Rajshekhar Karpoormath

Published date：--

DOI：10.1080/08927022.2022.2045016

Article link：http://dx.doi.org/10.1080/08927022.2022.2045016

Article Source：Informa UK Limited。

Remark：

Post time 2022-3-11 09:35:48

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-3-11 11:34:35

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-3-15 15:48:58

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Taylor&Francis] Structural based investigation of novel pyrazole-thiazole Hybrids as dual CDK-1 and CDK-2 inhibitors for cancer chemotherapy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today